TWO SIGMA ADVISERS, LP - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 69 filers reported holding RECRO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2022$23,000
+43.8%
14,100
-31.2%
0.00%
Q2 2022$16,000
-63.6%
20,500
-16.7%
0.00%
Q1 2022$44,000
-61.1%
24,600
-62.8%
0.00%
Q4 2021$113,000
-25.7%
66,100
-10.6%
0.00%
Q3 2021$152,000
+15.2%
73,900
+29.0%
0.00%
Q2 2021$132,000
-68.6%
57,300
-62.0%
0.00%
-100.0%
Q1 2021$421,000
-36.3%
150,900
-34.9%
0.00%
-50.0%
Q4 2020$661,000
-26.8%
231,800
-46.1%
0.00%
-33.3%
Q3 2020$903,000
-51.3%
429,800
+5.4%
0.00%
-40.0%
Q2 2020$1,856,000
-34.9%
407,900
+16.8%
0.01%
-54.5%
Q1 2020$2,853,000
-47.7%
349,200
+17.3%
0.01%
-15.4%
Q4 2019$5,459,000
+1564.3%
297,800
+906.1%
0.01%
+1200.0%
Q3 2019$328,000
+45.8%
29,600
+33.9%
0.00%0.0%
Q2 2019$225,000
+221.4%
22,100
+85.7%
0.00%
Q1 2019$70,000
-31.4%
11,900
-16.8%
0.00%
Q4 2018$102,000
-40.4%
14,300
-40.7%
0.00%
Q3 2018$171,000
-40.4%
24,100
-57.8%
0.00%
-100.0%
Q2 2018$287,000
+37.3%
57,100
+200.5%
0.00%0.0%
Q1 2018$209,00019,0000.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Engine Capital Management, LP 872,494$6,195,0003.64%
Newtyn Management, LLC 1,600,000$11,360,0002.22%
Broadfin Capital, LLC 2,048,025$14,541,0001.91%
Balter Liquid Alternatives, LLC 92,167$654,0000.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 515,414$3,660,0000.29%
JT Stratford LLC 45,367$322,0000.21%
Opus Point Partners Management, LLC 11,353$81,0000.18%
Alyeska Investment Group, L.P. 964,000$6,844,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 500,625$3,554,0000.09%
Monarch Partners Asset Management LLC 55,857$397,0000.06%
View complete list of RECRO PHARMA INC shareholders